BAMCO Inc’s Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share CTV.WS Stock Holding History

BAMCO Inc’s Portfolio CTV.WS Stock Details CTV.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,830,000	Closed	-$3.99M	–	365
2023 Q1	$3.99M	Sell	2,830,000 -257,657	-8%	-$68.9K	0.01%	274
2022 Q4	$5.28M	Hold	3,087,657	–	–	0.02%	271
2022 Q3	$8.37M	Sell	3,087,657 -1,114,897	-27%	-$492K	0.03%	245
2022 Q2	$6.98M	Sell	4,202,554 -505,103	-11%	-$344K	0.02%	266
2022 Q1	$28.4M	Buy	4,707,657 +4,622,355	+5,419%	+$4.11M	0.07%	196
2021 Q4	$95K	Buy	+85,302	New	+$106K	﹤0.01%	398

Other funds holding CTV.WS

LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

ICP

ION Crossover Partners Herzliya Pituach, Israel $36.9M AUM

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

IAM

Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

IAC

ION Acquisition Corp Herzliya, Israel $5.63M AUM 38.71% 1-Year Est. Return

Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return

BAMCO Inc's CTV.WS Position: Q2 2023 in Review

BAMCO Inc sold out of Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share (CTV.WS) in Q2 2023, closing a stake of 2,830,000 shares — an estimated $3.99M sold.

BAMCO Inc first reported a position in CTV.WS in Q4 2021 and held it in 6 quarters. The position peaked at $28.4M in Q1 2022. 20 funds tracked by Wall St. Rank hold CTV.WS as of Q2 2023.

BAMCO Inc reported no remaining Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position as of Q2 2023 after selling out during the quarter.
BAMCO Inc sold 2,830,000 Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share shares in Q2 2023, an estimated $3.99M.
BAMCO Inc first reported a position in Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share in Q4 2021 and held it in 6 quarters.
BAMCO Inc's Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share position peaked at $28.4M in Q1 2022.
20 funds tracked by Wall St. Rank held Innovid Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 per share as of Q2 2023.

Based on BAMCO Inc's 13F filing for Q2 2023, filed 14 Aug 2023.